Minimal Residual Disease (Mrd) in Non‐hodgkin Lymphomas: Inter‐laboratory Reproducibility on Marrow Samples With Very Low Levels of Disease Within the Fil (Fondazione Italiana Linfomi) MRD Network

Hematological Oncology - United Kingdom
doi 10.1002/hon.2652
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Clofarabine-Based Bridging Regimen in Patients With Relapsed ALL and Persistent Minimal Residual Disease (MRD)

Bone Marrow Transplantation
TransplantationHematology
2013English

Preventing Relapse After Haematopoietic Stem Cell Transplantation for Acute Leukaemia: The Role of Post-Transplantation Minimal Residual Disease (MRD) Monitoring and MRD-directed Intervention

British Journal of Haematology
Hematology
2017English

Minimal Residual Disease (Mrd) in Early Stage Follicular Lymphoma Can Predict Prognosis and Drive Rituximab Treatment After Radiotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Do Cytogenetics Predict Likelihood to Attain Minimal Residual Disease (MRD) Post Autologous Stem Cell Transplantation (SCT) in Multiple Myeloma (MM)?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Statistics and Measurable Residual Disease (MRD) Testing: Uses and Abuses in Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2019English

Novel Molecular Markers for Minimal Residual Disease (Mrd) Monitoring in Mantle Cell and Follicular Lymphoma: The Targeted Locus Amplification (Tla) NGS Strategy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Measurable Residual Disease (MRD) Detection by Next Generation Sequencing (NGS) in Acute Lymphoblastic LEUKAEMIA (ALL)

Pathology
Forensic MedicinePathology
2020English

Monitoring of Minimal Residual Disease (MRD) by Real-Time Quantitative Reverse Transcription PCR (RQ-RT-PCR) in Childhood Acute Myeloid Leukemia With AML1/ETO Rearrangement

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy